TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24494737

Group type: EXPERIMENTAL
Intervention: Bilateral sacroiliac joint manipulation and mobilization without tension of the hips in supine position
Number of subjects: 62

Group type: COMPARATOR
Intervention: Mobilization without tension of the hips in supine position
Number of subjects: 62
Study: 22677023

Group type: EXPERIMENTAL
Intervention: Intra-articular ozone gas injection (2 mL ozone-oxygen mixture, ozone gas concentration 10 μg/mL, injected 2 times per week for 3 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonsteroidal antiinflammatory drugs and muscle relaxants
Number of subjects: 60
Study: 20509987

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT) for anxiety disorders
Number of subjects: 99
Study: 17828004

Group type: EXPERIMENTAL
Intervention: Supportive-educative approach
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Mutual goal-setting approach
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 88
Study: 16052246

Group type: EXPERIMENTAL
Intervention: Lamotrigine (200 mg daily) plus oxcarbazepine (600 mg twice daily)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lamotrigine (200 mg daily) plus placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (600 mg twice daily) plus placebo
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 12369475

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 58
Study: 9987807

Group type: EXPERIMENTAL
Intervention: Naltrexone (NLTX)
Number of subjects: 2
Study: 7780494

Group type: EXPERIMENTAL
Intervention: Dexfenfluramine (15 mg twice daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2175265

Group type: EXPERIMENTAL
Intervention: 5 mg delta‐9‐tetrahydrocannabinol (THC) p.o.
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: 50 mg codeine p.o.
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 7002181

Group type: EXPERIMENTAL
Intervention: Oxyfedrine (24 mg three times daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Isosorbide dinitrate (10 mg three times daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 29712500

Group type: EXPERIMENTAL
Intervention: Fentanyl (continuous infusion of fentanyl)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control (continuous infusion of glucose)
Number of subjects: 53
Study: 28341683

Group type: EXPERIMENTAL
Intervention: Black tea intake (cups per day)
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Total fluid intake (cups per day)
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Water intake (cups per day)
Number of subjects: 1055

Group type: EXPERIMENTAL
Intervention: Other fluids intake (cups per day)
Number of subjects: 1055
Study: 26012124

Group type: EXPERIMENTAL
Intervention: Colonic J-pouch anastomosis
Number of subjects: 80

Group type: COMPARATOR
Intervention: Latero-terminal anastomosis
Number of subjects: 80
Study: 23895258

Group type: EXPERIMENTAL
Intervention: Integrated treatment for alcohol and social phobia (9 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment for alcohol use problems alone (9 sessions)
Number of subjects: 0
Study: 21823550

Group type: EXPERIMENTAL
Intervention: Remoxy (extended-release oxycodone) 5 mg bid to 20 mg bid, titrated during weeks 1-4 (10-80 mg/d) and fixed thereafter for 12 weeks
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Remoxy
Number of subjects: 558

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 558
Study: 18371962

Group type: EXPERIMENTAL
Intervention: Monopolar electrodes using glycine 1.5% as irrigant
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TCRis bipolar electrodes using saline as irrigant
Number of subjects: 200

Group type: COMPARATOR
Intervention: Versapoint bipolar electrodes using saline as irrigant
Number of subjects: 200

Group type: COMPARATOR
Intervention: Bipolar electrodes (TCRis and Versapoint)
Number of subjects: 200
Study: 17066515

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) + alpha-adrenergic antagonist
Number of subjects: 52
Study: 12848902

Group type: EXPERIMENTAL
Intervention: Hemostatic gene polymorphisms (beta-fibrinogen and platelet glycoprotein Ia, Ib, and IIb/IIIa)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sex- and age-matched controls
Number of subjects: 0
Study: 11139093

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG) with internal mammary artery (IMA) graft
Number of subjects: 0
Study: 9377884

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 36
Study: 8442747

Group type: EXPERIMENTAL
Intervention: Thought suppression with distraction instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thought suppression without distraction instructions
Number of subjects: 0
Study: 3676185

Group type: EXPERIMENTAL
Intervention: 5 mg supplementary vitamin E/d
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 15 mg supplementary vitamin E/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31307844

Group type: EXPERIMENTAL
Intervention: Sleep-study guided multidisciplinary therapy (SGMT)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 159
Study: 29218448

Group type: EXPERIMENTAL
Intervention: Spa treatment including thermal water baths, physical therapy modalities, and exercises
Number of subjects: 80

Group type: COMPARATOR
Intervention: Home exercises for 15 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spa treatment
Number of subjects: 80
Study: 26929878

Group type: EXPERIMENTAL
Intervention: Third trimester ultrasonographic exams (USE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine prenatal care (RPNC)
Number of subjects: 50
Study: 24782426

Group type: EXPERIMENTAL
Intervention: Flutamide (a selective non-steroidal AR antagonist)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 23321191

Group type: EXPERIMENTAL
Intervention: Partial axillary node dissection
Number of subjects: 1127

Group type: COMPARATOR
Intervention: Conventional dissection
Number of subjects: 1127
Study: 19888994

Group type: EXPERIMENTAL
Intervention: Tissue Doppler Imaging (TDI)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (healthy children)
Number of subjects: 32
Study: 17689737

Group type: EXPERIMENTAL
Intervention: Direct coronary artery stenting with drug eluting stents
Number of subjects: 68

Group type: COMPARATOR
Intervention: Stenting after balloon predilatation
Number of subjects: 68
Study: 16840657

Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion (5 microg/h for 3 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: rhIL-6 infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: albumin infusion (control)
Number of subjects: 12
Study: 15087636

Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Epidural morphine
Number of subjects: 14
Study: 11297480

Group type: EXPERIMENTAL
Intervention: LASIK for myopia (n=35, -1.00 to -15.50 D, mean -4.75 +/- -3.07 D)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: LASIK for myopic astigmatism (n=22, sphere 0.00 to -9.75 D, mean -4.75 +/- 2.36 D; cylinder -0.75 to -3.50 D, mean -1.68 +/- 0.86 D)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: LASIK with RBT <= 250 microm
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 57
Study: 9270508

Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream 0.05% applied three times weekly
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream 0.05% applied once weekly
Number of subjects: 126

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 126
Study: 7933724

Group type: EXPERIMENTAL
Intervention: Variable practice during intertrial intervals
Number of subjects: 80

Group type: COMPARATOR
Intervention: Criterion task alone
Number of subjects: 80
Study: 3474212

Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 40
Study: 28845523

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly subcutaneous for 12 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: COMPARATOR
Intervention: Dupilumab vs. Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 64
Study: 27029704

Group type: EXPERIMENTAL
Intervention: Palbociclib plus fulvestrant
Number of subjects: 521

Group type: COMPARATOR
Intervention: Fulvestrant plus placebo
Number of subjects: 521
Study: 24088635

Group type: EXPERIMENTAL
Intervention: Minimally invasive strabismus surgery (MISS)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard paralimbal strabismus surgery (SPSS)
Number of subjects: 14
Study: 23430192

Group type: EXPERIMENTAL
Intervention: Insulin glargine (GLA) at bedtime
Number of subjects: 75

Group type: COMPARATOR
Intervention: Metformin (MET) 1,000 mg b.i.d.
Number of subjects: 75
Study: 20507786

Group type: EXPERIMENTAL
Intervention: Sutures
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Human fibrin glue
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: N-butyl-2-cyanoacrylate
Number of subjects: 156

Group type: COMPARATOR
Intervention: Fibrin glue
Number of subjects: 156
Study: 18256777

Group type: EXPERIMENTAL
Intervention: Tibolone 1.25 mg/day
Number of subjects: 308

Group type: COMPARATOR
Intervention: Raloxifene 60 mg/day
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 308
Study: 16573256

Group type: EXPERIMENTAL
Intervention: MAS063DP cream
Number of subjects: 218

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 218
Study: 12729864

Group type: EXPERIMENTAL
Intervention: Aripiprazole (2 to 30 mg daily)
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 1549
Study: 10740336

Group type: EXPERIMENTAL
Intervention: Fish oil (Pikasol)
Number of subjects: 1579

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 1579
Study: 8638521

Group type: EXPERIMENTAL
Intervention: Nitrates
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 0
Study: 1490136

Group type: EXPERIMENTAL
Intervention: Educational intervention to increase involvement of minority leaders in AIDS-related efforts
Number of subjects: 166

Group type: COMPARATOR
Intervention: Religious leaders
Number of subjects: 166

Group type: COMPARATOR
Intervention: Agency directors
Number of subjects: 166
Study: 3815461

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Clindamycin-gentamicin
Number of subjects: 91
Study: 30204483

Group type: EXPERIMENTAL
Intervention: Slow-Digesting, Low-Glycemic Load (SD-LGL) beverage (GL 730)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isocaloric control beverage (GL 1124)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 16
Study: 27257747

Group type: EXPERIMENTAL
Intervention: dCBT (n=135)
Number of subjects: 270

Group type: COMPARATOR
Intervention: WL (n=135)
Number of subjects: 270
Study: 24452791

Group type: EXPERIMENTAL
Intervention: ARCON (accelerated radiotherapy combined with carbogen breathing and nicotinamide)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Accelerated radiotherapy
Number of subjects: 345
Study: 22409385

Group type: EXPERIMENTAL
Intervention: Autologous fibroblast therapy
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study: 20089463

Group type: EXPERIMENTAL
Intervention: Healthy body image program
Number of subjects: 421

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 421
Study: 18327364

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dorzolamide 2% 3 times daily and Timolol 0.5% twice daily
Number of subjects: 120
Study: 15771757

Group type: EXPERIMENTAL
Intervention: Ursofalk suspension
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ursofalk capsules
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ursofalk suspension and capsules
Number of subjects: 24
Study: 12606917

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine 0.5 ml/kg with 2 microg/kg neostigmine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.2% ropivacaine 0.5 ml/kg
Number of subjects: 0
Study: 10463904

Group type: EXPERIMENTAL
Intervention: Breast conserving techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant systemic treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: National breast screening programme
Number of subjects: 0
Study: 8946504

Group type: EXPERIMENTAL
Intervention: 20-hour fast group
Number of subjects: 126

Group type: COMPARATOR
Intervention: 26-hour fast group
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Celiac children in the 20-hour fast group
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: IBS children in the 20-hour fast group
Number of subjects: 126
Study: 1658138

Group type: EXPERIMENTAL
Intervention: UK 79300 100 mg every 12 h (group 2)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: UK 79300 25 mg every 12 h (group 1)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6302937

Group type: EXPERIMENTAL
Intervention: Topical application of Human-fibroblast-derived (Beta) interferon (Hu1FN-B) at a dosage of 2-5 x 10(5) reference units daily for one week.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical application of Human-fibroblast-derived (Beta) interferon (Hu1FN-B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified treatment)
Number of subjects: 0
Study: 31332918

Group type: EXPERIMENTAL
Intervention: H pylori infection
Number of subjects: 5558

Group type: COMPARATOR
Intervention: Control (no H pylori infection)
Number of subjects: 5558
Study: 29022084

Group type: EXPERIMENTAL
Intervention: trastuzumab emtansine (T-DM1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: capecitabine plus lapatinib (control)
Number of subjects: 0
Study: 25730407

Group type: EXPERIMENTAL
Intervention: Grief-specific music therapy in addition to standard care
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 10
Study: 24304680

Group type: EXPERIMENTAL
Intervention: Very low-intensity (30% 1RM) knee extension exercise with continuous muscle contraction (LST)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Intermitted muscle contraction (CON)
Number of subjects: 18
Study: 22292139

Group type: EXPERIMENTAL
Intervention: Tooth-clenching exercises at clenching levels of 10%, 20%, or 40% of maximal voluntary clenching.
Number of subjects: 41
Study: 19308464

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve block with additional continuous sciatic nerve block
Number of subjects: 54

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 54
Study: 17599335

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 50 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15204391

Group type: EXPERIMENTAL
Intervention: Desmopressin (0.4 mg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Anticholinergic medication (5-10 mg)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Combination treatment (after 4 weeks of monotherapy)
Number of subjects: 66
Study: 12362011

Group type: EXPERIMENTAL
Intervention: Telephone counseling sessions (up to seven sessions)
Number of subjects: 3282

Group type: COMPARATOR
Intervention: Self-help materials + counseling (if called back)
Number of subjects: 3282

Group type: EXPERIMENTAL
Intervention: Remaining subjects in treatment group (after factoring out counseling)
Number of subjects: 3282

Group type: COMPARATOR
Intervention: Remaining subjects in control group (after factoring out counseling)
Number of subjects: 3282

Group type: EXPERIMENTAL
Intervention: Those who made at least one attempt to quit in treatment group
Number of subjects: 3282

Group type: COMPARATOR
Intervention: Those who made at least one attempt to quit in control group
Number of subjects: 3282
Study: 11113067

Group type: EXPERIMENTAL
Intervention: rhuIL-10 8 microg/kg
Number of subjects: 329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: rhuIL-10 1 microg
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: rhuIL-10 4 microg
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: rhuIL-10 8 microg
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: rhuIL-10 20 microg
Number of subjects: 329
Study: 8653830

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (2 g)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 1294345

Group type: EXPERIMENTAL
Intervention: Bromergon (5 mg daily from cycle day 10 to onset of menstruation for two consecutive cycles)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Bromergon
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 6375840

Group type: EXPERIMENTAL
Intervention: 3% acyclovir ointment
Number of subjects: 66

Group type: COMPARATOR
Intervention: 3% vidarabine ointment
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 66
Study: 31013594

Group type: EXPERIMENTAL
Intervention: 800 IU of RRR‐alpha‐tocopherol
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study: 30448886

Group type: EXPERIMENTAL
Intervention: 23G PPV
Number of subjects: 103

Group type: COMPARATOR
Intervention: 20G PPV
Number of subjects: 103
Study: 27604620

Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IA)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE)
Number of subjects: 21
Study: 24885779

Group type: EXPERIMENTAL
Intervention: Internet-delivered positive imagery cognitive bias modification intervention
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 35
Study: 23061642

Group type: EXPERIMENTAL
Intervention: Automated self-management calls plus home blood pressure monitoring
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual healthcare
Number of subjects: 200
Study: 20499046

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg twice daily for 16 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 18340440

Group type: EXPERIMENTAL
Intervention: Local anesthetic administered to the vocal folds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal kinesthesia (no anesthetic)
Number of subjects: 0
Study: 15994610

Group type: EXPERIMENTAL
Intervention: Ultrasonography followed by immediate surgical repair
Number of subjects: 752

Group type: COMPARATOR
Intervention: Standard clinical examination (Control)
Number of subjects: 752
Study: 12642973

Group type: EXPERIMENTAL
Intervention: 15-minute lecture intervention on completing a MedWatch form
Number of subjects: 78

Group type: COMPARATOR
Intervention: Non-intervention (no lecture)
Number of subjects: 78
Study: 10412782

Group type: EXPERIMENTAL
Intervention: Atorvastatin, 20 mg/day
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 8758152

Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 31
Study: 1758242

Group type: EXPERIMENTAL
Intervention: N2O and isoflurane (Forane) discontinued simultaneously
Number of subjects: 24
Study: 30066454

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy
Number of subjects: 876

Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 876
Study: 30257282

Group type: EXPERIMENTAL
Intervention: Saphenous vein composite grafts
Number of subjects: 219

Group type: COMPARATOR
Intervention: Right internal thoracic artery composite grafts
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Saphenous vein second limb conduits
Number of subjects: 219

Group type: COMPARATOR
Intervention: Right internal thoracic artery second limb conduits
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Freedom from major adverse cardiac and cerebrovascular events
Number of subjects: 219
Study: 27578305

Group type: COMPARATOR
Intervention: Ingenol mebutate gel (IMB) for 3 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy with methyl aminolevulinate (MAL-PDT) for a single session
Number of subjects: 0
Study: 24316574

Group type: EXPERIMENTAL
Intervention: Satiety responsiveness
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Slowness in eating
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Food responsiveness
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Enjoyment of food
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Energy intake of snacks
Number of subjects: 37
Study: 21402493

Group type: EXPERIMENTAL
Intervention: Motiva system (educational videos, motivational messages, and questionnaires)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Motiva system + telemonitoring of blood pressure, heart rate and weight
Number of subjects: 97
Study: 20927422

Group type: EXPERIMENTAL
Intervention: Triclosan-containing mouthrinse and triclosan-containing dentifrice (group TT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control mouthrinse and triclosan-containing dentifrice (group CT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triclosan-containing mouthrinse and control dentifrice (group TC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control mouthrinse and control dentifrice (group CC)
Number of subjects: 40
Study: 17513395

Group type: COMPARATOR
Intervention: Meal A (50 g complete amino acid mixture without extra arginine)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Meal B (50 g complete amino acid mixture with 3 g extra arginine)
Number of subjects: 9